Cargando…
Nitazoxanide: A first-in-class broad-spectrum antiviral agent
Originally developed and commercialized as an antiprotozoal agent, nitazoxanide was later identified as a first-in-class broad-spectrum antiviral drug and has been repurposed for the treatment of influenza. A Phase 2b/3 clinical trial recently published in The Lancet Infectious Diseases found that o...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author. Published by Elsevier B.V.
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113776/ https://www.ncbi.nlm.nih.gov/pubmed/25108173 http://dx.doi.org/10.1016/j.antiviral.2014.07.014 |